For cash (domestic)
| Company | CLEEN Energy AG |
|---|---|
| ISIN | AT0000A1PY49 |
| from1 | 3,915,779 |
| by1 | 200,000 |
| to1 | 4,115,779 |
| Date | 04/07/2021 |
| First price2 | 5.10 |
| Market | Official Market |
| Market segment | standard market auction |
| Company | PORR AG |
| ISIN | AT0000609607 |
| from1 | 29,095,000 |
| by1 | 10,183,250 |
| to1 | 39,278,250 |
| Date | 11/08/2021 |
| First price2 | follows |
| Market | Official Market |
| Market segment | prime market |
Exercise of subscription or conversion rights (domestic)
| Company | CA IMMOBILIEN ANLAGEN AG |
|---|---|
| ISIN | AT0000641352 |
| from1 | 98,808,332 |
| by1 | 7,616,849 |
| to1 | 106,425,181 |
| Date | 04/29/2021 |
| Market | Official Market |
| Market segment | prime market |
| Company | CLEEN Energy AG |
| ISIN | AT0000A1PY49 |
| from1 | 4,115,779 |
| by1 | 114,285 |
| to1 | 4,230,064 |
| Date | 04/05/2021 |
| Market | Official Market |
| Market segment | standard market auction |
| Company | CA IMMOBILIEN ANLAGEN AG |
| ISIN | AT0000641352 |
| from1 | 106,425,181 |
| by1 | 71,241 |
| to1 | 106,496,422 |
| Date | 09/13/2021 |
| Market | Official Market |
| Market segment | prime market |
| Company | Marinomed Biotech AG |
| ISIN | ATMARINOMED6 |
| from1 | 1,477,044 |
| by1 | 3,116 |
| to1 | 1,480,160 |
| Date | 11/30/2021 |
| Market | Official Market |
| Market segment | prime market |
Shares of stock option programs (domestic)
| Company | Marinomed Biotech AG | - |
|---|---|---|
| ISIN | ATMARINOMED6 | - |
| from1 | 1,472,660 | - |
| by1 | 2,071 | - |
| to1 | 1,474,731 | - |
| Date | 01/12/2020 | - |
| Market | Official Market | - |
| Market segment | prime market | - |
| Company | Marinomed Biotech AG | - |
| ISIN | ATMARINOMED6 | - |
| from1 | 1,474,731 | - |
| by1 | 1,585 | - |
| to1 | 1,476,316 | - |
| Date | 07/20/2021 | - |
| Market | Official Market | - |
| Market segment | prime market | - |
| Company | Marinomed Biotech AG | - |
| ISIN | ATMARINOMED6 | - |
| from1 | 1,476,316 | - |
| by1 | 728 | - |
| to1 | 1,477,044 | - |
| Date | 10/28/2021 | - |
| Market | Official Market | - |
| Market segment | prime market | - |
Capital increase (domestic)
| Company | BIOGENA GROUP INVEST AG |
|---|---|
| ISIN | ATBIOGENA005 |
| from1 | 1,994,998 |
| by1 | 1,995,000 |
| to1 | 3,989,998 |
| Date | 05/06/2021 |
| Market | Vienna MTF |
| Market segment | direct market plus |
| Company | WOLFTANK-ADISA HOLDING AG |
| ISIN | AT0000A25NJ6 |
| from1 | 1,111,000 |
| by1 | 216,556 |
| to1 | 1,327,556 |
| Date | 05/14/2021 |
| Market | Vienna MTF |
| Market segment | direct market plus |
| Company | VST BUILDING TECHNOLOGIES AG |
| ISIN | AT0000A25W06 |
| from1 | 2,550,000 |
| by1 | 50,000 |
| to1 | 2,600,000 |
| Date | 06/28/2021 |
| Market | Vienna MTF |
| Market segment | direct market plus |
| Company | WOLFTANK-ADISA HOLDING AG |
| ISIN | AT0000A25NJ6 |
| from1 | 3,982,668 |
| by1 | 398,266 |
| to1 | 4,380,934 |
| Date | 11/30/2021 |
| Market | Vienna MTF |
| Market segment | direct market plus |
Capital increase (foreign)
| Company | HEALTH BIOSCIENCES SPA |
|---|---|
| ISIN | IT0005355984 |
| from1 | 10 828 639 |
| by1 | 123 331 |
| to1 | 10 951 970 |
| Date | 02/19/2021 |
| Market | Vienna MTF |
| Market segment | direct market |
| Company | LOCOSOCO GROUP PLC |
| ISIN | GB00BD5BTL23 |
| from1 | 12,283,733 |
| by1 | 1,580,000 |
| to1 | 13,863,733 |
| Date | 03/15/2021 |
| Market | Vienna MTF |
| Market segment | direct market |
| Company | AmeriMark Group AG |
| ISIN | US7551115071 |
| from1 | 20,000,000 |
| by1 | 6,800,000 |
| to1 | 26,800,000 |
| Date | 05/14/2021 |
| Market | Vienna MTF |
| Market segment | direct market |
| Company | WEALTH DRAGONS GROUP PLC |
| ISIN | GB00BGMGZR93 |
| from1 | 19,608,454 |
| by1 | 104,379 |
| to1 | 19,712,833 |
| Date | 07/02/2021 |
| Market | Vienna MTF |
| Market segment | direct market |
| Company | VOQUZ LABS AG |
| ISIN | DE000A3CSTW4 |
| from1 | 500,000 |
| by1 | 25,000 |
| to1 | 525,000 |
| Date | 10/07/2021 |
| Market | Vienna MTF |
| Market segment | direct market plus |
Overview of Corporate Actions
Capital increases
Stock splits and reverse stock splits
Capital decreases
Capital adjustments